pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·5h ago·1 min read
save

Bristol Myers Squibb announces $2.3 billion manufacturing campus in Houston

Aug 10, 2026·read at Endpoints ↗DealPositive

Bristol Myers Squibb disclosed plans to build a new manufacturing campus in Houston, Texas, with an estimated cost of $2.3 billion.

The campus will expand the company's domestic production capacity and is part of the broader investment pledge the firm made last year to increase U.S. manufacturing.

The announcement was made on Monday and includes details about the site location and expected timeline, though specific operational dates were not provided.

The investment underscores Bristol Myers Squibb's commitment to strengthening its supply chain in the United States and may create jobs in the region.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Bristol Myers details new $2.3B manufacturing campus in Houston”

read at Endpoints ↗
78 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BRISTOL4BRISTOL MYERS SQUIBB3BRISTOL MYERS SQUIBB CO3

related stories

  • May 29Bristol Myers unveils data for one of its next-gen blood cancer drugsBioPharma Dive
  • May 29Replimune takes third swing at cancer drug approval following ‘productive’ FDA talksBioPharma Dive
  • May 29Pfizer, Innovent strike $10B cancer drug dealBioPharma Dive
  • May 19STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much moreSTAT
  • May 18STAT+: Supreme Court rejects challenge to Medicare drug price negotiationSTAT